ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 361 out of 5176

$734K Total Retail Price of All Prescriptions

Rank: 559 out of 5176

239 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 239 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 239 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 12,114 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 527 527 1 3
DONEPEZIL HCL 507 507 2 28
POLYETHYLENE GLYCOL 3350 452 435 3 74
FUROSEMIDE 445 429 4 8
LEVOTHYROXINE SODIUM 441 428 5 4
MIRTAZAPINE 387 387 6 45
METOPROLOL TARTRATE 380 380 7 6
NAMENDA 345 345 8 47
WARFARIN SODIUM 332 332 9 13
JANTOVEN 296 296 10 106
AMLODIPINE BESYLATE 262 262 11 2
HYDROCODONE-ACETAMINOPHEN 225 205 S3 12 27
LISINOPRIL 184 184 13 5
METFORMIN HCL 183 172 14 7
CITALOPRAM HBR 177 177 15 31
POTASSIUM CHLORIDE 174 170 16 34
ISOSORBIDE MONONITRATE ER 167 167 17 44
LOVASTATIN 163 163 18 46
CIPROFLOXACIN HCL 150 149 19 84
CARVEDILOL 146 146 20 24
GABAPENTIN 146 131 20 21
SIMVASTATIN 144 144 22 1
ALENDRONATE SODIUM 140 140 23 18
DIGOXIN 136 136 24 56
ENALAPRIL MALEATE 133 133 25 22
SERTRALINE HCL 131 131 26 30
LANTUS 128 128 27 66
NYSTATIN-TRIAMCINOLONE 125 125 28 142
NYSTOP 121 115 29 283
PANTOPRAZOLE SODIUM 116 116 30 61
CARBIDOPA-LEVODOPA 114 92 31 98
ATORVASTATIN CALCIUM 110 110 32 9
CLOPIDOGREL 105 105 33 26
RANITIDINE HCL 103 89 34 36
METOPROLOL SUCCINATE 97 84 35 11
DIVALPROEX SODIUM 88 88 36 104
JANUVIA 88 88 36 25
OXYCODONE HCL 83 83 S2 38 121
HUMULIN R 83 83 38 347
IPRATROPIUM-ALBUTEROL 80 78 40 138
CEFPODOXIME PROXETIL 77 75 41 399
PLAVIX 76 76 42 29
METOCLOPRAMIDE HCL 68 68 43 176
PREDNISONE 65 65 44 52
FENTANYL 65 65 S2 44 172
NOVOLIN R 64 64 46 191
KLOR-CON M20 64 56 46 129
SSD 62 62 48 216
ATENOLOL 61 61 49 12
NYSTATIN 60 60 50 168
DIOVAN 59 59 51 19
CLONIDINE HCL 58 58 52 79
PRAVASTATIN SODIUM 57 57 53 23
METHADONE HCL 56 28 S2 54 310
NITROGLYCERIN PATCH 55 55 55 149
HYDROCORTISONE 54 54 56 265
LEVOFLOXACIN 53 51 57 109
AMITIZA 53 53 57 197
CRESTOR 52 52 59 15
EXELON 51 51 60 162
TAMSULOSIN HCL 50 43 61 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.